A clandestine network of Silicon Valley executives, venture capitalists, and high ranking Trump administration officials has spent the last year operating within a private Slack workspace to reshape the landscape of American healthcare. This digital inner circle has provided elite firms including Google, Microsoft, OpenAI, and Apple a direct line to regulators at the Food and Drug Administration and the Centers for Medicare and Medicaid Services. Through this hidden channel, tech leaders have lobbied for a future where AI powered health apps face looser regulations and can bill the government directly for services, mirroring the reimbursement model used by licensed medical professionals.

The secrecy surrounding these collaborations has raised significant legal concerns. Internal documents and messages obtained by KFF Health News reveal that key policy sessions were organized via the chat app rather than through official public calendars or regulatory notices. While federal law typically requires advisory panels to operate transparently, this slack community functioned as a shadow board where industry insiders could nudge agency guidance without public oversight. Among the most influential figures in the room was Amy Gleason, formerly of the Department of Government Efficiency, who helped curate a membership list dominated by tech founders and investors while largely excluding patient advocates and frontline physicians.

Government officials have framed this push as part of a broader vision called the Health Technology Ecosystem designed to empower patients with seamless access to their own medical records. CMS Administrator Mehmet Oz described the initiative as allowing industry players to play in the sandbox of government supported healthcare, while HHS Secretary Robert F. Kennedy Jr. has praised AI as being potentially better informed than any individual doctor in the country. To facilitate this transition, the government has even introduced a Medicare App Library intended to act as a lucrative pipeline connecting millions of seniors to selected commercial software tools.

However, members of the medical community are sounding alarms over the speed and opacity of these changes. Dr. John Whyte of the American Medical Association warned that many of these emerging tools are not yet ready for primetime, citing a dangerous lack of data regarding their accuracy and a total absence of clear liability when AI provides incorrect medical advice. As tech companies gain unprecedented access to sensitive patient data under the guise of innovation, critics argue that profit motives are being prioritized over clinical safety and transparency in what is effectively becoming a privatized wing of federal health policy.

Post Views: 7